CMS

Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Fierce Pharma
Novartis
legal
Inflation Reduction Act
CMS
drug pricing
Entresto
Flag link:
AARP urges courts to keep drug pricing talks on track
AARP urges courts to keep drug pricing talks on track
Yahoo Finance
AARP
legal
HHS
drug pricing
Medicare
CMS
amicus brief
Flag link:
The 10 drugs that CMS might wrangle into negotiations
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Flag link:
Medicare’s Proposed Coverage for Alzheimer’s Scan Could Be Boon for Eisai/Biogen
Medicare’s Proposed Coverage for Alzheimer’s Scan Could Be Boon for Eisai/Biogen
BioSpace
CMS
Alzheimer's disease
Eisai
Biogen
PET scans
Flag link:
Medicare proposes coverage for PrEP without patient cost sharing
Medicare proposes coverage for PrEP without patient cost sharing
Fierce Healthcare
Medicare
CMS
HIV
PrEP
Flag link:
Medicare has no surprises in planned registry for new Alzheimer’s drugs
Medicare has no surprises in planned registry for new Alzheimer’s drugs
BioPharma Dive
Medicare
Alzheimer's disease
CMS
Flag link:
CMS proposes new pathway for reimbursing breakthrough devices
CMS proposes new pathway for reimbursing breakthrough devices
Stat
devices
Medtech
CMS
breakthrough devices
Flag link:
PhRMA cries foul on CMS' registry approach for Alzheimer's disease drugs
PhRMA cries foul on CMS' registry approach for Alzheimer's disease drugs
Fierce Pharma
Biogen
Eisai
Alzheimer's disease Leqembi
CMS
PhRMA
Flag link:
Medicaid plans to audit the prices of costliest drugs
Medicaid plans to audit the prices of costliest drugs
ABC News
White House
drug pricing
Medicaid
CMS
Flag link:
Pharma Decries Drug Selection Plans in Medicare Pricing Policy
Pharma Decries Drug Selection Plans in Medicare Pricing Policy
RAPS.org
Medicare
drug pricing
CMS
Inflation Reduction Act
Flag link:
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Flag link:
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Flag link:
US lawmakers again propose diagnostics reform bill
US lawmakers again propose diagnostics reform bill
RAPS.org
legislation
FDA
diagnostics
CMS
Flag link:
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Fierce Pharma
Pfizer
Bristol Myers Squibb
Eliquis
drug pricing
Inflation Reduction Act
CMS
Flag link:
Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO
Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO
Fierce Pharma
Eisai
Leqembi
FDA
CMS
Alzheimer's disease
Flag link:
Alzheimer's Association campaigns for broader Leqembi coverage: report
Alzheimer's Association campaigns for broader Leqembi coverage: report
Fierce Pharma
CMS
Eisai
Biogen
Leqembi
Alzheimer's disease
Flag link:
CMS lays out plans for negotiating drug prices
CMS lays out plans for negotiating drug prices
BioPharma Dive
CMS
Medicare
drug pricing
Flag link:
8 Moments that Defined Diabetes Tech
8 Moments that Defined Diabetes Tech
Medical Devices and Diagnostics Industry
diabetes
Medtech
Medtronic
Sensionics
Verily
Embecta
DexCom
Apple
CMS
Abbott Labs
Flag link:
Medicare maintains limits on Eisai’s new Alzheimer’s drug
Medicare maintains limits on Eisai’s new Alzheimer’s drug
BioPharma Dive
Medicare
CMS
Eisai
Biogen
Leqembi
Alzheimer's disease
Flag link:
CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies
CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies
American Journal of Managed Care
drug pricing
CMS
Medicare
Medicaid
accelerated approval
Flag link:

Pages